University of Aberdeen
Overview
The University of Aberdeen is a public research university that invests in and supports the commercialisation of spin-out companies originating from its research, particularly in sectors like life sciences and technology. It also manages an endowment fund that provides capital to other investment funds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nevrargenics Ltd | Dec 2019 | Seed | Co-investor |
| EnteroBiotix | May 2019 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is University of Aberdeen based?
University of Aberdeen is headquartered in Aberdeen, United Kingdom.
When was University of Aberdeen founded?
University of Aberdeen was founded in 1495.
How many portfolio companies does University of Aberdeen have?
University of Aberdeen has 2 portfolio companies in Caplight's dataset.
What are some companies in University of Aberdeen's portfolio?
Portfolio companies visible on Caplight include Nevrargenics Ltd, EnteroBiotix.
What was University of Aberdeen's most recent investment shown here?
University of Aberdeen's most recent investment in this portfolio sample was in Nevrargenics Ltd in 2019.
What sectors does University of Aberdeen focus on?
University of Aberdeen focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does University of Aberdeen focus on?
University of Aberdeen typically invests at the Early stage.
What is University of Aberdeen's AUM?
University of Aberdeen's assets under management are estimated between $50.0M and $100.0M.